Insulin glargine and lixisenatide Subcutaneous and Tinidazole Tablets
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Tinidazole Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: tinidazole
Brand name: Tindamax, Fasigyn
Synonyms: Tinidazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Tinzaparin
- Insulin glargine and lixisenatide Subcutaneous-Tinzaparin Subcutaneous
- Insulin glargine and lixisenatide Subcutaneous-Tiotropium
- Insulin glargine and lixisenatide Subcutaneous-Tiotropium and Olodaterol
- Insulin glargine and lixisenatide Subcutaneous-Tiotropium and olodaterol Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Tiotropium Bromide
- Tinidazole Tablets-Insulin glargine, recombinant Subcutaneous
- Tinidazole Tablets-Insulin glulisine
- Tinidazole Tablets-Insulin Glulisine (Cartridges and Pens)
- Tinidazole Tablets-Insulin Glulisine (Vials)
- Tinidazole Tablets-Insulin glulisine Subcutaneous
- Tinidazole Tablets-Insulin human inhaled Inhalation